drug
LEVOCETIRIZINE DIHYDROCHLORIDE
Marketedupdated 3mo agoby Chattem Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5all catalysts(12)
approval · 12
Sep 17, 2013
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Oct 1, 2015
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Oct 1, 2015
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Aug 31, 2017
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Aug 31, 2017
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Aug 31, 2017
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Aug 31, 2017
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Jun 13, 2025
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Jun 13, 2025
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Jun 13, 2025
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Jul 11, 2025
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Jan 7, 2026
approval
LEVOCETIRIZINE DIHYDROCHLORIDE — FDA approval
LEVOCETIRIZINE DIHYDROCHLORIDE
→
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 16, 2027
~1.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Oct 16, 2027formulationUS 86331941.2y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that